Free Trial
NYSE:CAH

Cardinal Health (CAH) Stock Price, News & Analysis

Cardinal Health logo
$167.92 +0.74 (+0.44%)
As of 03:58 PM Eastern

About Cardinal Health Stock (NYSE:CAH)

Key Stats

Today's Range
$166.58
$168.40
50-Day Range
$131.32
$167.18
52-Week Range
$93.17
$168.39
Volume
3.40 million shs
Average Volume
2.24 million shs
Market Capitalization
$40.08 billion
P/E Ratio
26.20
Dividend Yield
1.20%
Price Target
$157.43
Consensus Rating
Moderate Buy

Company Overview

Cardinal Health, Inc. (NYSE: CAH) is a diversified health care services and products company that provides pharmaceuticals and medical products to a broad range of customers, including hospitals, health systems, pharmacies and ambulatory surgery centers. Founded in 1971 and headquartered in Dublin, Ohio, the company has grown through strategic acquisitions and organic expansion to become one of the largest global distributors of generic pharmaceuticals and medical-surgical supplies.

The company’s operations are organized into two primary segments: Pharmaceutical and Medical. In its Pharmaceutical segment, Cardinal Health distributes branded and generic drugs, over-the-counter products and specialty pharmaceuticals. The Medical segment offers a wide array of products such as surgical gloves, exam gloves, fluid management products, infection prevention solutions and clinical nutrition supplies. Both segments are supported by value-added services, including supply chain analytics, inventory management, pharmacy automation and consulting services designed to optimize operational efficiency for health care providers.

With operations in more than 45 countries, Cardinal Health maintains a vast logistics network of distribution centers, hubs and cross-dock facilities, enabling timely delivery of critical products. The company also partners with manufacturers, group purchasing organizations and government entities to enhance access to medicines and medical supplies in both mature and emerging markets. In recent years, it has expanded its presence in Asia, Europe and Latin America, while investing in digital platforms to support e-commerce and data-driven decision-making across its customer base.

Leadership at Cardinal Health is led by President and Chief Executive Officer Mike Kaufmann, who assumed the role in April 2022. Under his guidance, the company has prioritized operational excellence, quality assurance and sustainability initiatives. The executive team continues to focus on innovation in supply chain solutions and expanding specialty drug services to address evolving needs in patient care and health care delivery systems worldwide.

AI Generated. May Contain Errors.

Cardinal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
96th Percentile Overall Score

CAH MarketRank™: 

Cardinal Health scored higher than 96% of companies evaluated by MarketBeat, and ranked 51st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 11 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cardinal Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Cardinal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Cardinal Health are expected to grow by 12.58% in the coming year, from $7.95 to $8.95 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardinal Health is 26.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardinal Health is 26.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.46.

  • Price to Earnings Growth Ratio

    Cardinal Health has a PEG Ratio of 1.87. PEG Ratios above 1 indicate that a company could be overvalued.

  • Read more about Cardinal Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.41% of the float of Cardinal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardinal Health has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardinal Health has recently decreased by 2.88%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cardinal Health pays a meaningful dividend of 1.21%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Cardinal Health has been increasing its dividend for 29 years.

  • Dividend Coverage

    The dividend payout ratio of Cardinal Health is 31.51%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 22.57% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

  • Read more about Cardinal Health's dividend.
  • Percentage of Shares Shorted

    2.41% of the float of Cardinal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardinal Health has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardinal Health has recently decreased by 2.88%, indicating that investor sentiment is improving.
  • News Sentiment

    Cardinal Health has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 30 news articles for Cardinal Health this week, compared to 19 articles on an average week.
  • Search Interest

    14 people have searched for CAH on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • MarketBeat Follows

    Only 8 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardinal Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.09% of the stock of Cardinal Health is held by insiders.

  • Percentage Held by Institutions

    87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardinal Health's insider trading history.
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

CAH Stock News Headlines

CAH - Cardinal Health Inc Chart - Morningstar
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Cardinal Health stock hits all-time high at 166.33 USD
See More Headlines

CAH Stock Analysis - Frequently Asked Questions

Cardinal Health's stock was trading at $118.27 at the beginning of 2025. Since then, CAH stock has increased by 42.0% and is now trading at $167.92.
View the best growth stocks for 2025 here
.

Cardinal Health, Inc. (NYSE:CAH) posted its quarterly earnings results on Thursday, May, 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The firm's revenue for the quarter was up .0% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Cardinal Health: Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and others.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Broadcom (AVGO), AbbVie (ABBV) and Chevron (CVX).

Company Calendar

Record date for 4/15 Dividend
4/01/2025
Ex-Dividend for 4/15 Dividend
4/01/2025
Dividend Payable
4/15/2025
Last Earnings
5/01/2025
Today
6/30/2025
Fiscal Year End
6/30/2025
Record date for 7/15 Dividend
7/01/2025
Ex-Dividend for 7/15 Dividend
7/01/2025
Dividend Payable
7/15/2025
Next Earnings (Estimated)
8/13/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Distributors
Current Symbol
NYSE:CAH
Employees
46,500
Year Founded
1971

Price Target and Rating

Average Stock Price Target
$157.43
High Stock Price Target
$181.00
Low Stock Price Target
$124.00
Potential Upside/Downside
-6.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
26.23
Forward P/E Ratio
21.15
P/E Growth
1.87
Net Income
$852 million
Pretax Margin
0.95%

Debt

Sales & Book Value

Annual Sales
$226.83 billion
Cash Flow
$10.60 per share
Price / Cash Flow
15.87
Book Value
($13.19) per share
Price / Book
-12.75

Miscellaneous

Free Float
238,462,000
Market Cap
$40.14 billion
Optionable
Optionable
Beta
0.66

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:CAH) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners